Wall Street analysts expect LHC Group, Inc. (NASDAQ:LHCG) to report $295.25 million in sales for the current quarter, according to Zacks. Five analysts have issued estimates for LHC Group’s earnings. The highest sales estimate is $298.60 million and the lowest is $293.64 million. LHC Group reported sales of $246.62 million in the same quarter last year, which indicates a positive year over year growth rate of 19.7%. The business is scheduled to issue its next quarterly earnings report on Wednesday, May 2nd.
According to Zacks, analysts expect that LHC Group will report full year sales of $295.25 million for the current fiscal year, with estimates ranging from $1.85 billion to $1.86 billion. For the next fiscal year, analysts forecast that the firm will report sales of $2.19 billion per share, with estimates ranging from $2.16 billion to $2.21 billion. Zacks Investment Research’s sales calculations are a mean average based on a survey of sell-side research analysts that that provide coverage for LHC Group.
LHC Group (NASDAQ:LHCG) last announced its quarterly earnings data on Wednesday, February 28th. The health services provider reported $0.62 earnings per share (EPS) for the quarter, meeting the Zacks’ consensus estimate of $0.62. LHC Group had a return on equity of 9.18% and a net margin of 4.67%. The firm had revenue of $292.40 million for the quarter, compared to analysts’ expectations of $280.82 million. During the same period last year, the firm earned $0.58 earnings per share. The company’s revenue for the quarter was up 24.2% compared to the same quarter last year.
Shares of NASDAQ:LHCG traded down $1.66 on Monday, reaching $69.65. 589,498 shares of the company traded hands, compared to its average volume of 302,749. LHC Group has a 52 week low of $51.38 and a 52 week high of $76.14. The stock has a market capitalization of $1,303.92, a P/E ratio of 28.78, a price-to-earnings-growth ratio of 1.15 and a beta of 0.70. The company has a current ratio of 1.97, a quick ratio of 1.97 and a debt-to-equity ratio of 0.28.
In other news, COO Donald Dwayne Stelly sold 14,216 shares of the stock in a transaction dated Tuesday, March 13th. The shares were sold at an average price of $64.00, for a total transaction of $909,824.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Corporate insiders own 14.80% of the company’s stock.
Several institutional investors have recently bought and sold shares of the company. American International Group Inc. boosted its holdings in shares of LHC Group by 7.2% during the third quarter. American International Group Inc. now owns 12,533 shares of the health services provider’s stock worth $889,000 after purchasing an additional 840 shares during the period. OppenheimerFunds Inc. boosted its holdings in shares of LHC Group by 10.4% during the fourth quarter. OppenheimerFunds Inc. now owns 11,388 shares of the health services provider’s stock worth $698,000 after purchasing an additional 1,071 shares during the period. Cornercap Investment Counsel Inc. boosted its holdings in shares of LHC Group by 10.2% during the fourth quarter. Cornercap Investment Counsel Inc. now owns 11,845 shares of the health services provider’s stock worth $726,000 after purchasing an additional 1,095 shares during the period. Crossmark Global Holdings Inc. boosted its holdings in shares of LHC Group by 28.0% during the fourth quarter. Crossmark Global Holdings Inc. now owns 5,036 shares of the health services provider’s stock worth $308,000 after purchasing an additional 1,103 shares during the period. Finally, Comerica Bank boosted its holdings in shares of LHC Group by 9.1% during the third quarter. Comerica Bank now owns 17,125 shares of the health services provider’s stock worth $1,145,000 after purchasing an additional 1,426 shares during the period. Institutional investors own 89.87% of the company’s stock.
COPYRIGHT VIOLATION NOTICE: “LHC Group, Inc. (LHCG) Expected to Post Quarterly Sales of $295.25 Million” was originally posted by Ticker Report and is the sole property of of Ticker Report. If you are viewing this news story on another website, it was illegally stolen and reposted in violation of US & international trademark & copyright law. The correct version of this news story can be accessed at https://www.tickerreport.com/banking-finance/3344284/lhc-group-inc-lhcg-expected-to-post-quarterly-sales-of-295-25-million.html.
About LHC Group
LHC Group, Inc is a holding company. The Company provides post-acute healthcare services to patients through its home nursing agencies, hospice agencies, community-based services agencies and long-term acute care hospitals (LTACHs). The Company operates through four segments: home health services, hospice services, community-based services and facility-based services.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.